LIFTDERM
Itraconazole 1% w/w + Ofloxacin 0.75% w/w + Ornidazole 2% w/w + Clobetasol 0.05% w/w cream.
LIFTDERM Cream from Bioglint Derma Care is a topical dermatological formulation containing Clobetasol Propionate 0.05% w/w, Ofloxacin 0.75% w/w, Ornidazole 2% w/w, and Itraconazole 1% w/w. It is available as a 15 gm cream and is included in Bioglint Derma Care’s dermatology cream range.
The formulation combines an antifungal, antibacterial, antimicrobial, and corticosteroid component and is intended for use in selected inflammatory skin conditions where infection may also be involved. Because it contains Clobetasol Propionate, a potent topical corticosteroid, it should be used only under appropriate medical guidance.
Clinical Applications of LIFTDERM Cream
Itraconazole is an antifungal agent, while Ofloxacin is an antibacterial agent. Ornidazole has antimicrobial activity, and Clobetasol Propionate is a potent topical corticosteroid used to reduce inflammation and associated symptoms in certain skin conditions.
LIFTDERM Cream may therefore be considered by a healthcare professional when a combination topical formulation is appropriate for a particular inflammatory or infected skin condition. The product should be applied only as directed by a qualified healthcare professional, particularly because prolonged or inappropriate use of potent corticosteroids can cause unwanted skin effects.
Clobetasol, Ofloxacin, Ornidazole & Itraconazole Cream PCD Pharma Franchise Opportunity with Bioglint Derma Care
Bioglint Derma Care offers a broad range of dermatology products, including topical creams, antifungal preparations, antibacterial formulations, steroids, and combination dermatological medicines. LIFTDERM is listed within the company’s Cream portfolio and can be considered by pharma professionals, distributors, and entrepreneurs looking to expand their dermatology product range.
Bioglint Derma Care states that it provides dermatology products through pharmaceutical marketing opportunities and offers monopoly-based PCD Derma Franchise opportunities.
Why Choose LIFTDERM Cream for Your Franchise Portfolio?
- Contains Itraconazole 1% w/w
- Contains Ofloxacin 0.75% w/w
- Contains Ornidazole 2% w/w
- Contains Clobetasol Propionate 0.05% w/w
- Multi-component dermatological cream formulation
- Combines antifungal, antibacterial, antimicrobial, and anti-inflammatory properties
- Available in a convenient 15 gm pack
- Suitable addition to a dermatology and skin-care medicine portfolio
Partner with Bioglint Derma Care
For pharma professionals looking to expand their portfolio in the dermatology and topical skin-care segment, LIFTDERM Cream can be considered as a combination dermatological formulation within the Bioglint Derma Care product range. If you are looking for an Itraconazole, Ofloxacin, Ornidazole & Clobetasol Cream PCD Pharma Franchise, LIFTDERM may be considered as part of your product portfolio. Contact Bioglint Derma Care for current information regarding product availability, territory options, franchise requirements, pricing, packaging, and business terms.
Disclaimer – LIFTDERM Cream should be used only according to the advice of a qualified healthcare professional and the current prescribing information. It is intended for topical use. Because the formulation contains Clobetasol Propionate, prolonged, excessive, or unsupervised use may cause adverse skin effects.
